Xometry, Inc. operates a marketplace that enables buyers to source manufactured parts and assemblies in the United States and internationally. It provides CNC machining, milling, and turning services; sheet, laser, waterjet, and plasma cutting services; and sheet metal forming services. The company also offers 3D printing services, such as carbon digital light synthesis, fused deposition modeling, HP multi jet fusion, PolyJet, selective laser sintering, stereolithography, metal 3D printing service, direct metal laser sintering, and metal binder jetting; and injection molding services, including plastic injection, over, insert, and prototype molding, as well as bridge and production tooling Please visit their website for more information.
*Proprietary Buy Sell Volume Indicator
Revenue: $142M |
Revenue Growth (YOY): 19.15% |
Profit (% of Rev): 39.40% |
Income (% of Rev): -7.20% |
Income Growth (YOY): -15.17% |
Operating Income: $-11M |
Operating Cash Flow: $-4M |
Operating Cash Flow Growth (YoY): -38.99% |
Annual Dividend Yield: 0.15% |
Total Assets: $678M |
Total Liabilities: $362M |
Cash & Equivalent: $17M |
Total Debt: $297M |
Debt/Equity: 0.94 |
Quick Ratio: 4.55 |
Current Ratio: 4.59 |
Price/Book: 2.87 |
Price/Earnings: -22.19 |
EBITDA: $-11M |
EPS: -0.21 |
Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Buy.
TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.
Contact @ support@theoryofstocks.com
© 2024 Stock Articles. All rights reserved.